Guideline on medicines for the treatment of amyotrophic lateral sclerosis released for a six-month public consultation

View source ↗

Summary

The EMA released a guideline outlining medicines for treating amyotrophic lateral sclerosis (ALS) and opened it for a six-month public consultation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis